{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:49Z","timestamp":1793134129038,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jacc.2013.05.069","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T09:09:23Z","timestamp":1372324163000},"page":"1365-1372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":354,"title":["PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)"],"prefix":"10.1016","volume":"62","author":[{"given":"Martin","family":"Huelsmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Neuhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Resl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Brath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Francesconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Adlbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Clodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.05.069_bib1","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib3","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.05.069_bib7","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib10","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMe1002498","article-title":"ACCORD and risk-factor control in type 2 diabetes","volume":"362","author":"Nilsson","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.05.069_bib11","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/eurheartj\/ehn334","article-title":"NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus","volume":"29","author":"Huelsmann","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.05.069_bib12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2362.2011.02539.x","article-title":"Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus","volume":"41","author":"Neuhold","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2013.05.069_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/1741826711420015","article-title":"A\u00a0comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus","volume":"19","author":"Clodi","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2013.05.069_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00125-004-1607-0","article-title":"Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria","volume":"48","author":"Gaede","year":"2005","journal-title":"Diabetologia"},{"issue":"Suppl 5","key":"10.1016\/j.jacc.2013.05.069_bib15","first-page":"S1","article-title":"Osterreichische Diabetes Gesellschaft Diabetes Mellitus. Guidelines for the practice. Revised and expanded 2007 edition","volume":"121","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jacc.2013.05.069_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc07-9917","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"30","author":"Buse","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2013.05.069_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.05.069_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacc.2004.05.071","article-title":"Prognostic role of b-type natriuretic peptide levels in patients with type 2 diabetes mellitus","volume":"44","author":"Bhalla","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.05.069_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.amjcard.2005.05.050","article-title":"B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus","volume":"96","author":"Dawson","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.05.069_bib20","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-006-0359-4","article-title":"Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes","volume":"49","author":"Tarnow","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2013.05.069_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.05.069_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2012.10.011","article-title":"A\u00a0meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure","volume":"61","author":"Savarese","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.05.069_bib23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/HJH.0b013e328337a9fd","article-title":"Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea","volume":"28","author":"Grassi","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2013.05.069_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.healun.2007.07.030","article-title":"Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents","volume":"26","author":"Frankenstein","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2013.05.069_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2009.02.095","article-title":"N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure. Results from the BATTLESCARRED (NT-proBNP\u2013Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial","volume":"55","author":"Lainchbury","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.05.069_bib26","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. The\u00a0STARS-BNP multicenter study","volume":"49","author":"Jourdain","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.05.069_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713025175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713025175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:01:17Z","timestamp":1760014877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713025175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":27,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0735109713025175"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.05.069","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2013.05.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}